Juraj Smaha

Dr. Juraj Smaha

5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Bratislava, Bratislavský, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
FMFilip Max
Filip Max
Andrea GažováAndrea Gažová
Andrea Gažová
JSJuraj Smaha
Juraj Smaha
MJMartin Jankovský
Martin Jankovský
TTTomas Tesar
Tomas Tesar
JKJan Kyselovic
Jan Kyselovic
Background/Objectives: Type II diabetes mellitus (T2DM) is recognized as a condition of mild chronic inflammation, marked by increased levels of acute-phase proteins and various inflammatory indicators. These inflammatory substances, along with inflammation of adipose tissue and the secretion of adipocytokines, can contribute to insulin resistance and β cell dysfunction. By influencing both innate and adaptive immunity, vitamin D can inhibit the production of inflammatory cytokines and help mitigate the low-grade chronic inflammation associated with T2DM. Several strategies have been proposed to increase vitamin D levels effectively and safely, but the recent and strong ones have common tactics. Short-term high doses increase the level acutely, and long-term lower doses maintain sufficient levels. Methods: The aim of our work was to determine and verify the effectiveness of high doses of vitamin D to safely increase its level in patients with type 2 diabetes mellitus, as well as the effect of these doses on selected metabolic parameters. Data from 20 studies (vitamin D group n = 612, and control group n = 592) regarding the influence of vitamin D supplementation with doses above 4000 IU on serum 25(OH)D, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), blood pressure, serum calcium, and parathormone were pooled. Results: Vitamin D supplementation significantly improved serum 25(OH)D levels, with an average increase after intervention versus baseline at 177.09%. Our studies suggest that vitamin D supplementation may benefit various parameters in T2DM patients, including glycemic control, blood pressure, and PTH levels. Conclusions: Vitamin D supplementation may have beneficial effects on various parameters in type 2 diabetes patients, including glycemic control, blood pressure, and parathormone levels. However, the results are only sometimes consistent across all studies. Further examination is needed.

7 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JSJuraj Smaha
Juraj Smaha
MKMartin Kužma
Martin Kužma
PJPeter Jackuliak
Peter Jackuliak
SNSamuel Nachtmann
Samuel Nachtmann
FMFilip Max
Filip Max
JPJuraj Payer
Juraj Payer
It is unclear how ongoing inflammation in Coronavirus Disease 2019 (COVID-19) affects 25-hydroxyvitamin D (25[OH]D) concentration. The objective of our study was to examine serum 25(OH)D levels during COVID-19 pneumonia. Patients were admitted between 1 November and 31 December 2021. Blood samples were taken on admission (day 0) and every 24 h for the subsequent four days (day 1–4). On admission, 59% of patients were 25(OH)D sufficient (>30 ng/mL), and 41% had 25(OH)D inadequacy (<30 ng/mL). A significant fall in mean 25(OH)D concentration from admission to day 2 (first 48 h) was observed (30.7 ng/mL vs. 26.4 ng/mL; p < 0.0001). No subsequent significant change in 25(OH)D concentration was observed between day 2 and 3 (26.4 ng/mL vs. 25.9 ng/mL; p = 0.230) and day 3 and day 4 (25.8 ng/mL vs. 25.9 ng/mL; p = 0.703). The absolute 25(OH)D change between hospital admission and day 4 was 16% (4.8 ng/mL; p < 0.0001). On day 4, the number of patients with 25(OH)D inadequacy increased by 18% (p = 0.018). Therefore, serum 25(OH)D concentration after hospital admission in acutely ill COVID-19 patients should be interpreted with caution. Whether low 25(OH)D in COVID-19 reflects tissue level vitamin D deficiency or represents only a laboratory phenomenon remains to be elucidated in further prospective trials of vitamin D supplementation.

23 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
JSJuraj Smaha
Juraj Smaha
PJPeter Jackuliak
Peter Jackuliak
MKMartin Kužma
Martin Kužma
FMFilip Max
Filip Max
NBNeil Binkley
Neil Binkley
JPJuraj Payer
Juraj Payer
The coronavirus disease 2019 (COVID-19) pandemic has led to changes in lifestyle, which could influence vitamin D status on a population level. The purpose of our study was to compare 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized because of severe COVID-19 during two waves of the pandemic (2020/21 vs. 2021/22). A total of 101 patients from the 2021/22 wave were compared with 101 sex- and age-matched subjects from the 2020/21 wave. Patients from both groups were hospitalized during the winter season from 1 December to 28 February. Men and women were analyzed together and separately. The mean 25(OH)D concentration increased from 17.8 ± 9.7 ng/mL to 25.2 ± 12.6 ng/mL between waves. The prevalence of vitamin D deficiency (30 ng/mL) increased from 10% to 34% (p < 0.0001). The proportion of patients with a history of vitamin D supplementation increased from 18% to 44% (p < 0.0001). Low serum 25(OH)D concentration was independently associated with mortality after adjusting for age and sex for the whole cohort of patients (p < 0.0001). The prevalence of inadequate vitamin D status in hospitalized patients with COVID-19 in Slovakia decreased significantly, probably due to a higher rate of vitamin D supplementation during the COVID-19 pandemic.

22 January 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
JSJuraj Smaha
Juraj Smaha
MKMartin Kužma
Martin Kužma
KBKristína Brázdilová
Kristína Brázdilová
SNSamuel Nachtmann
Samuel Nachtmann
MJMartin Jankovský
Martin Jankovský
JPJuraj Payer
Juraj Payer
There is no consensus on specific serum 25-hydroxy vitamin D (25(OH) D) levels associated with higher risk of severe outcome in patients with coronavirus disease 2019 (COVID-19). According to the literature patients with serum 25(OH) D levels <12 ng/ml are clearly deficient at all ages. Our aim was to assess COVID-19 mortality in the settings of severe 25(OH) D deficiency. A cohort study of 357 patients with COVID-19 was conducted. Subjects were monitored until discharge or in-hospital death. At admission, severity parameters (C-reactive protein (CRP), IL-6, Charlson comorbidity index, etc.) were assessed. These parameters were compared regarding 25(OH) D levels threshold 12 ng/ml, where values below 12 ng/ml were considered absolute vitamin D deficiency. 25(OH) D levels at the time of admission were independently associated with mortality (p <0.05). Nonsurvivors (N = 168) had lower 25(OH) D levels, SO2, higher age, CRP, viral load, and Charlson comorbidity index in comparison to survivors. Patients with serum 25(OH) D levels 12 ng/ml (p <0.05). Patients with COVID-19 with serum 25(OH) D levels <12 ng/ml have higher mortality. Among other factors, severe vitamin D deficiency likely leads to poor outcome.

12 June 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
OHOrsolya Hrubá
Orsolya Hrubá
LŽLucia Žigová
Lucia Žigová
MHMichala Hrončová
Michala Hrončová
SVSimona Valaskova
Simona Valaskova
JSJuraj Smaha
Juraj Smaha
Andrea GažováAndrea Gažová
Andrea Gažová
Objectives: The “weekend effect” refers to the higher risk of death for patients admitted to hospitals on weekends compared to weekdays. While this pattern is well documented in many countries, there is limited data from Central Europe, including Slovakia. Study Design: We conducted a 13-year retrospective study at a large internal medicine department in Bratislava, Slovakia, to determine (1) whether there is a weekend effect, (2) which patient groups are most affected, and (3) what clinical and demographic factors might play a role. Methods: Using statistical tests, we analysed 45,955 hospitalisations between 2010 and 2022, comparing mortality rates between weekday (Monday–Friday) and weekend (Saturday–Sunday) admissions. We also used logistic regression to adjust for age, gender, length of stay, and re-hospitalisation. Causes of death were classified using ICD-10 codes. Results: Patients admitted on weekends had a significantly higher in-hospital mortality rate (15.58%, 1203 deaths among 7719 admissions) than patients admitted on weekdays (10.47%, 4002 deaths among 38,236 admissions, p < 0.0001). Even after adjusting for other factors, weekend admission remained a strong predictor of death (adjusted odds ratio = 1.31, 95% CI: 1.22–1.41). Cardiovascular disease was the most common cause of death on weekends. The weekend effect persisted across all years and was particularly pronounced in the COVID-19 pandemic (2020–2021). Conclusions: Our findings confirm the weekend effect in Slovakia, with patients admitted on weekends facing a higher risk of in-hospital death. Identifying the reasons behind this trend is critical to improving hospital care and ensuring consistent quality of care throughout the week.

6 March 2026 in International Journal for Vitamin and Nutrition Research
Verified
Journal Article
Open access
PDF file
FMFilip Max
Filip Max
TTTomas Tesar
Tomas Tesar
Andrea GažováAndrea Gažová
Andrea Gažová
JSJuraj Smaha
Juraj Smaha
MJMartin Jankovský
Martin Jankovský
JKJan Kyselovic
Jan Kyselovic
Background/Objectives: Vitamin D is a pleiotropic molecule involved in various physiological processes beyond skeletal health, including immune modulation and metabolic regulation. This prospective observational biomedical study aimed to assess the impact of short-term high-dose vitamin D supplementation on selected metabolic parameters in adult patients with type 2 diabetes mellitus (T2DM) and low serum 25-hydroxyvitamin D [25(OH)D] concentrations. Methods: Thirty patients were enrolled and assigned to receive either 10,000 IU/day of cholecalciferol (Group A) or a significantly lower dose (960 IU/day, Group B) for 12 weeks based on recruitment order (odd/even identification numbers). The primary endpoints were changes in parathyroid hormone (PTH), fasting blood glucose (FBG), calcium, phosphorus, and glycated haemoglobin (HbA1c). Results: A strong, statistically significant negative correlation between changes in 25(OH)D and PTH (Spearman r = –0.69052, p = 0.0044) was also observed. In the high-dose group, 25(OH)D increased from 17.2 to 31.8 ng/mL (median change 13.3 ng/mL), while PTH decreased from 3.27 to 2.76 pmol/L (median change –0.27 pmol/L). In the lower-dose group, 25(OH)D increased from 18.5 to 28.2 ng/mL (median change +8.1 ng/mL). The increase in 25(OH)D was significantly greater in the high-dose group than in the lower-dose group (median change +13.3 vs +8.1 ng/mL, p = 0.015). Within the observed range, patients with larger increases in 25(OH)D tended to show greater reductions in PTH. Other metabolic markers (HbA1c, FBG, calcium, and phosphorus) remained stable over 12 weeks. Conclusions: These findings support the effectiveness and safety of high-dose vitamin D supplementation in correcting vitamin D deficiency and reducing PTH levels in patients with T2DM while highlighting the need for longer-term studies to evaluate its broader metabolic effects.